173 related articles for article (PubMed ID: 25054819)
1. Molecular neuro-oncology: a forward-looking perspective.
Wick W; O'Neill T
CNS Oncol; 2013 Nov; 2(6):491-3. PubMed ID: 25054819
[TBL] [Abstract][Full Text] [Related]
2. Neuro-oncology in 2015: Progress in glioma diagnosis, classification and treatment.
Wen PY; Reardon DA
Nat Rev Neurol; 2016 Feb; 12(2):69-70. PubMed ID: 26782337
[No Abstract] [Full Text] [Related]
3. Neuro-oncology: Implications of the molecular era.
Ruff MW; Uhm JH; Benarroch EE
Neurology; 2019 Mar; 92(12):568-574. PubMed ID: 30760635
[TBL] [Abstract][Full Text] [Related]
4. Primary brain tumors, delta 24 and tumor metabolism. Interview by Rona Williamson.
Gilbert MR
Expert Rev Neurother; 2013 Apr; 13(4):353-5. PubMed ID: 23545051
[TBL] [Abstract][Full Text] [Related]
5. Response assessment in neuro-oncology criteria: implementation challenges in multicenter neuro-oncology trials.
Pope WB; Hessel C
AJNR Am J Neuroradiol; 2011 May; 32(5):794-7. PubMed ID: 21474628
[No Abstract] [Full Text] [Related]
6. Biomarkers usher in era of personalized care for malignant glioma patients.
Chakravarti A; Palanichamy K; Bell EH
CNS Oncol; 2012 Sep; 1(1):3-6. PubMed ID: 25054291
[No Abstract] [Full Text] [Related]
7. A comprehensive approach in high-grade glioma management: position statement from the Neuro-Oncology Scientific Club (NOSC), Shiraz, Iran.
Ansari M; Mosalaei A; Ahmadloo N; Rasekhi A; Geramizadeh B; Razmkon A; Anvari K; Afarid M; Dadras A; Nafarieh L; Mohammadianpanah M; Nasrolahi H; Hamedi SH; Omidvari S; Nami M
Ger Med Sci; 2017; 15():Doc05. PubMed ID: 28325997
[TBL] [Abstract][Full Text] [Related]
8. Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study.
Kickingereder P; Isensee F; Tursunova I; Petersen J; Neuberger U; Bonekamp D; Brugnara G; Schell M; Kessler T; Foltyn M; Harting I; Sahm F; Prager M; Nowosielski M; Wick A; Nolden M; Radbruch A; Debus J; Schlemmer HP; Heiland S; Platten M; von Deimling A; van den Bent MJ; Gorlia T; Wick W; Bendszus M; Maier-Hein KH
Lancet Oncol; 2019 May; 20(5):728-740. PubMed ID: 30952559
[TBL] [Abstract][Full Text] [Related]
9. Correlative studies in neuro-oncology trials: should they influence treatment?
Hegi ME; Stupp R
Curr Oncol Rep; 2006 Jan; 8(1):54-7. PubMed ID: 16464404
[TBL] [Abstract][Full Text] [Related]
10. [Biomarkers of glioma: recent advance and potential applications].
Yu SZ; Wang Q
Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):145-7. PubMed ID: 19575846
[No Abstract] [Full Text] [Related]
11. Extracellular Vesicles as a Platform for Glioma Therapeutic Development.
Santiago-Dieppa DR; Gonda DD; Cheung VJ; Steinberg JA; Carter BS; Chen CC
Prog Neurol Surg; 2018; 32():172-179. PubMed ID: 29990983
[TBL] [Abstract][Full Text] [Related]
12. Neuro-oncology: diagnosis and management of cerebral gliomas--past, present, and future.
Gutin PH; Posner JB
Neurosurgery; 2000 Jul; 47(1):1-8. PubMed ID: 10917341
[No Abstract] [Full Text] [Related]
13. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.
Albert NL; Weller M; Suchorska B; Galldiks N; Soffietti R; Kim MM; la Fougère C; Pope W; Law I; Arbizu J; Chamberlain MC; Vogelbaum M; Ellingson BM; Tonn JC
Neuro Oncol; 2016 Sep; 18(9):1199-208. PubMed ID: 27106405
[TBL] [Abstract][Full Text] [Related]
14. [Magnetic resonance spectroscopy in gliomas].
Galanaud D; Chinot O; Metellus P; Cozzone P
Bull Cancer; 2005 Apr; 92(4):327-31. PubMed ID: 15888389
[TBL] [Abstract][Full Text] [Related]
15. Italian consensus and recommendations on diagnosis and treatment of low-grade gliomas. An intersociety (SINch/AINO/SIN) document.
Rudà R; Angileri FF; Ius T; Silvani A; Sarubbo S; Solari A; Castellano A; Falini A; Pollo B; Del Basso De Caro M; Papagno C; Minniti G; De Paula U; Navarria P; Nicolato A; Salmaggi A; Pace A; Fabi A; Caffo M; Lombardi G; Carapella CM; Spena G; Iacoangeli M; Fontanella M; Germanò AF; Olivi A; Bello L; Esposito V; Skrap M; Soffietti R;
J Neurosurg Sci; 2020 Aug; 64(4):313-334. PubMed ID: 32347684
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of prognostic and predictive factors into glioma clinical trials.
Johnson DR; Galanis E
Curr Oncol Rep; 2013 Feb; 15(1):56-63. PubMed ID: 23125011
[TBL] [Abstract][Full Text] [Related]
17. Parkinson's disease and the quest for preclinical diagnosis: an interview with Professor Werner Poewe.
Poewe W
Neurodegener Dis Manag; 2017 Oct; 7(5):273-277. PubMed ID: 29043906
[TBL] [Abstract][Full Text] [Related]
18. Translational research in gliomas: Quo Vadis?
Barnett GH
Clin Neurosurg; 2006; 53():154-6. PubMed ID: 17380747
[TBL] [Abstract][Full Text] [Related]
19. Response assessment in neuro-oncology.
Quant EC; Wen PY
Curr Oncol Rep; 2011 Feb; 13(1):50-6. PubMed ID: 21086192
[TBL] [Abstract][Full Text] [Related]
20. Introduction of our new associate editor.
Desjardins A; Gunawardana R
CNS Oncol; 2014; 3(5):327-8. PubMed ID: 25363004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
